Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Large Increase in Short Interest

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 1,190,000 shares, an increase of 201.5% from the December 15th total of 394,700 shares. Based on an average trading volume of 3,000,000 shares, the short-interest ratio is currently 0.4 days.

Wall Street Analyst Weigh In

AEMD has been the topic of several research analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a research note on Friday, November 15th. StockNews.com started coverage on shares of Aethlon Medical in a research note on Saturday. They issued a “sell” rating on the stock.

Aethlon Medical Trading Down 4.8 %

AEMD opened at $0.64 on Tuesday. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $2.10. The stock has a fifty day moving average price of $0.50 and a 200 day moving average price of $0.43. The stock has a market cap of $8.87 million, a price-to-earnings ratio of -0.23 and a beta of 1.61.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.